Growth Metrics

Enovis (ENOV) Profit After Tax Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -12.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.26%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 125.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 51.30%
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn 84.90%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 84.90%
Dec 31, 2025 25.93%
Oct 3, 2025 -1,711.95%
Jul 4, 2025 -97.43%
Apr 4, 2025 22.10%
Dec 31, 2024 -3,797.59%
Sep 27, 2024 -62.05%
Jun 28, 2024 -88.65%
Mar 29, 2024 -210.22%
Dec 31, 2023 71.61%
Sep 29, 2023 70.51%
Jun 30, 2023 -112.75%
Mar 31, 2023 -242.06%
Dec 31, 2022 63.88%
Sep 30, 2022 -355.14%
Jul 1, 2022 159.19%
Apr 1, 2022 -19.46%
Dec 31, 2021 -104.24%
Oct 1, 2021 53.53%
Jul 2, 2021 469.11%
Apr 2, 2021 267.47%
Dec 31, 2020 -350.16%
Oct 2, 2020 346.58%
Jul 3, 2020 98.28%
Apr 3, 2020 111.47%
Dec 31, 2019 -6.01%
Sep 27, 2019 -77.37%
Jun 28, 2019 -1,075.28%
Mar 29, 2019 -331.22%
Dec 31, 2018 119.85%
Sep 28, 2018 -66.43%
Jun 29, 2018 14.28%
Mar 30, 2018 -45.92%
Dec 31, 2017 -527.19%
Sep 29, 2017 22.38%
Jun 30, 2017 -4.93%
Mar 31, 2017 42.20%
Dec 31, 2016 -11.04%
Sep 30, 2016 72.21%
Jul 1, 2016 -25.14%
Apr 1, 2016 -52.03%
Dec 31, 2015 -43.43%
Sep 25, 2015 -71.04%
Jun 26, 2015 -70.34%
Mar 27, 2015 2.62%
Dec 31, 2014 94.12%
Sep 26, 2014 24.17%
Jun 27, 2014 195.15%
Mar 28, 2014 69.91%
Dec 31, 2013 76.31%
Sep 27, 2013 351.58%
Jun 28, 2013 260.67%
Mar 29, 2013 132.13%
Dec 31, 2012 255.88%
Sep 28, 2012 292.93%
Jun 29, 2012 79.33%
Mar 30, 2012 -1,632.59%
Dec 31, 2011 -285.90%
Sep 30, 2011 -36.93%
Jul 1, 2011 397.61%